Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Nasal cell collection to build a biobank for testing aerosol drugs

Official title: Collection of Primary Human Nasal Epithelial Cells

Run by University Hospital, Tours · NCT06407102 · Data updated 2026-11-12

Researchers will collect nasal cells during planned surgery to create a biobank and test aerosol drug delivery using air-liquid interface cultures.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Tours
Academic / other
Locations1 site (Tours)
StatusRecruiting
StartedDecember 6, 2024
Main results expectedMay 2, 2027
Study endsMay 2, 2028
Registry record updatedJune 16, 2026
Trial IDNCT06407102 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 who speak French, are affiliated with the French social security system, can consent in writing, and are scheduled for rhinologic surgery.

Probably not a fit

Participants whose tissue would not contribute to the biobank or who do not undergo usable nasal epithelial sampling may not directly benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project collects primary nasal epithelial cells from adults undergoing rhinologic surgery and grows them at the air–liquid interface to form a physiologic ex vivo model. The aim is to build a biobank of at least 60 samples and use these cells to study infection, inflammation, and potential aerosol therapies. This approach provides a human-relevant model that can reduce reliance on animal studies and help screen future aerosol drugs. The work focuses on maximizing cell yield, characterization, and context-specific testing conditions.

Why it matters

Potential benefit: If successful, the biobank could accelerate testing of inhaled therapies and improve understanding of nasal biology relevant to infections and inflammation.

How similar studies have gone: Previous work using nasal epithelial cells at the air–liquid interface has shown that such models can reflect airway biology and support drug testing, but commercial/biobank scale is still evolving.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age \> 18 years) whose native language is French, or who understands French.
* Affiliation with a French social security system (CMU accepted).
* Informed consent, written and signed by the participant.
* Planned rhinological surgery (meatotomy, septoplasty or turbinoplasty for example, but other surgeries as well)

Exclusion Criteria:

* Patients under court protection, guardianship or curatorship.
* Pregnant or breast-feeding women (positive pregnancy test for women of childbearing age).
* Patients presenting a major alteration of the mucosa or a malignant rhinosinus pathology.

Where it's running

  • Aussedat
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.